Skip to content

Cystinuria in Dogs: Newfoundland and Bulldog Stone Disease Guide

Cystinuria in Dogs: Newfoundland and Bulldog Stone Disease G

Last updated: May 16, 2026

What Cystinuria in Dogs Actually Is

Cystinuria in dogs is an inherited disorder of amino acid transport in the kidney’s proximal tubules. Normally, the renal tubules reabsorb cystine and other dibasic amino acids (ornithine, lysine, arginine) from the filtrate before they reach urine. In affected dogs, the transporter is defective, and these amino acids spill into urine. Cystine is the least soluble of the four and precipitates into crystals and stones in acidic urine, making cystine bladder and kidney stones the clinical signature of the disease. The other three amino acids cause no clinical signs themselves and serve as biochemical markers of the underlying disorder.

Cystinuria is not a single disease but a family of related transporter defects with different inheritance patterns and breed associations. Several distinct mutations have been identified, and the clinical course differs substantially between them. The most clinically significant distinction is between androgen-independent cystinuria (severe disease in both sexes) and androgen-dependent cystinuria (clinical disease primarily in intact male dogs, with neutering producing partial or complete resolution). Breed identification and genetic testing are central to choosing the right management.

The Genetics by Breed

Type I-A cystinuria is the most severe form and is autosomal recessive androgen-independent. It is the classic Newfoundland presentation — affected Newfoundlands of both sexes form recurrent stones, and clinical disease can begin in the first year of life. The mutation is in the SLC3A1 gene, and a genetic test is available. Affected Newfoundlands need lifelong intensive medical management.

Type II is autosomal dominant or codominant, also androgen-independent, and has been described in Australian Cattle Dogs, Miniature Pinschers, and other breeds. It is less common but produces severe disease similar to Type I-A.

Type III is androgen-dependent — clinical cystinuria appears primarily in intact male dogs and is much milder or absent in females and neutered males. The classic presentations are English Bulldog, French Bulldog, Mastiff, Dachshund, Staffordshire Bull Terrier, and Scottish Deerhound. Neutering is therapeutic for many Type III dogs and may produce complete resolution of stone-forming tendency.

Other unclassified or sporadic forms exist in additional breeds. The genetic landscape continues to be characterized as research progresses. Identifying the type by breed and genetic testing guides management decisions, especially the decision about neutering as therapy.

How Cystine Stones Form

Cystine is poorly soluble in acidic urine. As cystine concentration rises in urine and pH stays acidic, the amino acid precipitates into crystals — six-sided “benzene-ring” hexagonal crystals on microscopy that are pathognomonic when seen. Crystals aggregate into stones over weeks to months. Stones may remain in the bladder, lodge in the urethra (especially in male dogs with their longer narrower urethras), or migrate up into the ureters and obstruct urine flow.

The clinical course is one of recurrent stone disease. Even after surgical removal, stones reform if dietary, pharmacologic, and hydration management are not maintained. Recurrence rates in untreated cystinuric dogs approach a high fraction of cases within a year or two of surgical removal. Aggressive medical prevention is the difference between repeated surgeries and stable disease control.

What You Might See at Home

Owners notice the signs of urinary irritation rather than the cystine itself. Frequent trips to the yard with small urine production, straining to urinate, blood-tinged urine, urinating in unusual locations, and crying or vocalizing during urination all top the list. Affected dogs often have a long history of recurrent UTI, intermittent hematuria, and unexplained urinary signs that resolve briefly with antibiotic courses but recur.

The most dangerous progression is urethral obstruction in male dogs. Cystine stones lodging in the urethra produce true emergency disease — the dog cannot urinate, the bladder distends painfully, and within 24 to 72 hours, hyperkalemia and acute kidney injury develop. Any dog straining unproductively or unable to produce urine needs emergency vet care immediately. Recurrent obstruction is unfortunately common in untreated cystinuric males and may eventually require perineal urethrostomy (surgical creation of a wider, more proximal urinary opening that prevents future urethral stone obstruction).

How Veterinarians Diagnose Cystinuria

Diagnosis combines urinalysis, imaging, stone composition analysis, and breed-specific genetic testing. Cystine crystals on urinalysis (six-sided hexagonal crystals) are highly suggestive when present, though they are not always present in every urine sample even from affected dogs. The cyanide-nitroprusside test (a chemical screening test for urinary cystine) is positive in affected dogs and is a useful screening tool. Quantitative urine amino acid analysis at a reference laboratory provides definitive biochemical diagnosis.

Imaging follows. Cystine stones are weakly radiopaque to radiolucent — they may not show clearly on plain radiographs and are best visualized by abdominal ultrasound or contrast cystography. Abdominal ultrasound is the imaging modality of choice when cystinuria is suspected. Stone composition analysis after surgical removal is essential — submitting representative stones to a quantitative urolith analysis laboratory confirms cystine and characterizes any mixed-composition stones.

Genetic testing is available for several cystinuria mutations and is breed-specific. Newfoundland-specific testing for the SLC3A1 mutation is well established; other breed-specific tests are increasingly available through specialty laboratories. The University of Pennsylvania School of Veterinary Medicine has historically been a central referral resource for cystinuria research and testing — your vet can advise on the appropriate test for your breed. Our broader dog bladder stones overview covers the diagnostic landscape for all stone types.

Treatment: Surgery for Existing Stones

Existing cystine stones generally require surgical or interventional removal. Cystotomy is the standard procedure for bladder stones — opening the bladder, removing stones, flushing for retained sand, and submitting representative stones for analysis. Smaller stones may be retrieved with voiding urohydropulsion. Laser lithotripsy at referral centers can fragment stones via cystoscopy in select cases. Urethral obstruction requires emergency relief — retrograde catheterization to push the obstructing stone back into the bladder, or perineal urethrostomy in dogs with recurrent obstruction.

An ACVS surgical specialist may be appropriate for complex cases — recurrent disease, ureteral involvement, or anatomic complications. Perineal urethrostomy is a meaningful surgical commitment and changes urinary anatomy permanently, but it is sometimes the right choice for males with recurrent obstruction.

Medical Prevention: The Three-Pillar Approach

Recurrence prevention rests on three pillars working together: diet, alkalinization, and chelator therapy in select cases.

The first pillar is diet. A low-protein, low-methionine diet reduces cystine substrate availability. Your vet will prescribe a therapeutic urinary diet appropriate for cystinuria — these diets are formulated to produce less acidic urine with reduced sulfur amino acid content. The diet must be the sole food source. Treats and table scraps undermine the chemistry. Cystine-prevention diets are similar in formulation principle to renal-supportive diets and may overlap with prescriptions used for other urinary conditions.

The second pillar is urinary alkalinization. Cystine is more soluble in alkaline urine than acidic urine, and raising urine pH toward 7.0 to 7.5 reduces crystal formation substantially. Potassium citrate is the most commonly used alkalinizing agent; sodium bicarbonate is sometimes used. Urine pH is monitored at home with pH strips and during recheck visits, with dose adjustments as needed.

The third pillar is chelator therapy in select cases. 2-mercaptopropionylglycine (2-MPG, also called tiopronin) is a sulfur-containing chelator that combines with cystine in urine to form a more soluble compound. Tiopronin is reserved for dogs in whom diet and alkalinization alone are insufficient because side effects (proteinuria, blood dyscrasias) can occur and require monitoring. D-penicillamine is an older chelator with a similar mechanism but a less favorable side effect profile and is rarely used now. Your vet will dose by weight, disease severity, and lab response.

Neutering as Therapy

For Type III androgen-dependent cystinuria — the Bulldog, French Bulldog, Mastiff, Dachshund, and several other breeds — neutering is a meaningful therapeutic intervention. Removing the testosterone source often reduces or eliminates clinical stone formation. The conversation about neutering should occur early in the management plan for affected intact males. Neutering does not help Type I-A androgen-independent cystinuria (Newfoundland), where lifelong medical management is required regardless of reproductive status. Genetic typing helps inform whether neutering is likely to produce clinical benefit.

Long-Term Monitoring

Lifelong surveillance is essential. Periodic urinalysis with urine pH and crystal assessment, recheck imaging at intervals your vet sets (typically every six to twelve months for stable dogs, more frequently in active disease), and bloodwork to monitor for medication side effects (especially in dogs on tiopronin) are standard. Hydration optimization, multiple water bowls, water fountains, and canned food rotation all support the prevention strategy. Any signs of urinary irritation or changes in voiding behavior warrant prompt urinalysis and possibly imaging.

Concurrent disease management matters. Recurrent UTI is common in cystinuric dogs and requires prompt antibiotic treatment with culture-and-sensitivity guidance. Concurrent kidney disease may develop over time — see our chronic kidney disease in dogs guide for the long-arc framing.

Cost and Insurance

Lifelong management is a meaningful financial commitment. Therapeutic diet, alkalinization medications, possible chelator therapy, periodic recheck imaging, and recurrent surgical episodes all add up over a dog’s lifetime. Pet insurance for dogs purchased before symptoms appear covers most of these depending on the policy — and because cystinuria is hereditary, insurance may classify it as a pre-existing condition if stone disease has been documented before policy purchase. Read the policy fine print carefully. The veterinary specialist cost breakdown covers the broader fee landscape if interventional or referral-level options are needed.

Adoption and Breed-Specific Framing

Many cystinuric dogs live full, well-managed lives with appropriate intervention. If you’re considering adopting a Newfoundland, English Bulldog, French Bulldog, Mastiff, Dachshund, Staffordshire Bull Terrier, or Scottish Deerhound from rescue, ask about urinary screening as part of intake. Genetic testing where available can clarify risk before clinical disease develops. Breed-predisposed dogs warrant proactive discussion with the rescue and your vet about prevention. Affected dogs should not be bred — the inheritance pattern propagates the disease, and ethical breeders test breeding candidates and select away from affected lines.

The adopt-a-dog hub covers broader medical-history considerations. Many of the predisposed breeds — Bulldogs especially — have additional breed-related health considerations beyond cystinuria, and prospective adopters should research the full breed health profile.

Prognosis

Prognosis varies by genetic type, sex, neutering status, and management adherence. Type I-A Newfoundlands face lifelong intensive management with recurrent stone risk; well-managed dogs can live full lifespans but require persistent owner commitment. Type III intact males do well after neutering plus medical management, often with substantial reduction in stone-forming tendency. Type III neutered males and Type III females typically have less severe disease. Your vet will frame expectations based on genetic type, prior stone history, and response to management.

Frequently Asked Questions

Should my Bulldog with cystinuria be neutered?

For Type III androgen-dependent cystinuria, which is common in Bulldogs, neutering is a meaningful therapeutic intervention. Removing testosterone reduces or eliminates clinical stone formation in many affected males. Discuss the timing and considerations with your vet — neutering is often recommended early in the management plan for affected intact males.

Can cystine stones be dissolved with diet?

Some cystine stones can dissolve with aggressive medical management — alkalinization, low-protein diet, and chelator therapy — but dissolution is slower and less reliable than struvite dissolution. Most clinically significant cystine stones are removed surgically, with medical management focused on preventing new stone formation.

Is cystinuria the same in all breeds?

No. Cystinuria is a family of related disorders with different mutations, inheritance patterns, and clinical courses across breeds. Newfoundland Type I-A is severe and androgen-independent; Bulldog and Mastiff Type III is androgen-dependent and may resolve with neutering. Genetic testing where available helps clarify the specific subtype.

How often will my cystinuric dog need recheck imaging?

Schedules vary by individual disease severity and management response. Most cystinuric dogs receive recheck ultrasound every six to twelve months when stable, more frequently after surgical episodes or when signs return. Periodic urinalysis with urine pH and crystal assessment continues year-round.

Is cystinuria hereditary, and should affected dogs be bred?

Cystinuria is hereditary in all recognized forms, with breed-specific inheritance patterns. Affected dogs should not be bred — the inheritance propagates the disease in subsequent generations. Ethical breeders use available genetic tests to select breeding candidates and reduce affected-line incidence in predisposed breeds.

Ready to adopt?

Find your perfect companion from shelters and rescues near you.

Browse Adoptable Pets

Related articles

Why Does My Chinchilla Nibble Me?
Pet Care

Why Does My Chinchilla Nibble Me?

Wondering why does my chinchilla nibble me? Learn what gentle nibbling means, from grooming and affection to attention-seeking, and how to respond kindly.

Why Does My Chinchilla Rub His Chin?
Pet Care

Why Does My Chinchilla Rub His Chin?

Wondering why does my chinchilla rub his chin? Learn about scent marking, territory, and the rare dental signs that mean it is time to call an exotics vet.

Why Does My Chinchilla Cough?
Pet Care

Why Does My Chinchilla Cough?

Worried why does my chinchilla cough? Learn the dust, respiratory, and dental causes of coughing and exactly when to call an exotics vet right away.